Answers are grounded in this paper and cite their sources.
Decorin (DCN) is a small extracellular proteoglycan with significant oncosuppressive activity. Lung adenocarcinoma is commonly devoid of DCN expression and is a leading cause of cancer mortality globally. As a proof‐of‐concept study for evaluating the oncosuppressive potential of DCN expression in lung adenocarcinoma cells, we constructed an oncolytic herpes simplex virus type 1 (HSV‐1) vector, with a DCN transgene, using a transfection‐infection method. Treatment of the lung adenocarcinoma cell line A549 with this novel DCN‐expressing HSV‐1 vector led to a significantly increased oncolysis of the cells compared to the effect of the parental or control marker virus. These results support the further development of a DCN‐expressing oncolytic HSV‐1 for evaluation in in vivo models for the treatment of lung adenocarcinoma, as well as other types of cancers with underexpressed DCN.
No takes yet. Share an insight, caveat, or question.
Frejborg et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: